v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:    
Net income (loss) $ 22,246,292 $ (1,093,685)
Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract]    
Depreciation and amortization 3,135,216 2,875,363
Credit losses 270,925 354,661
Sales allowance 10,000 (60,000)
Allowance for obsolete inventory (15,636) 4,513
Deferred Taxes 2 16,484
Loss on monitoring equipment included in cost of revenue 200,740 268,217
Gain on troubled debt restructuring (23,464,004) 0
Amortization of debt issuance costs 131,964 61,891
Interest added to loan payable 90,514 0
Foreign currency exchange (gain) loss 742,055 210,708
Right of use assets/liabilities 5,496 5,390
Loss on disposal of assets 0 397
Revaluation of warrant liability (205,031) (0)
Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract]    
Accounts receivable, net 1,517,983 (1,831,773)
Inventories, net (120,904) (627,485)
Current assets held for sale 0 719,201
Prepaid expense, deposits and other assets (278,211) (134,165)
Noncurrent assets 0 (10,614)
Accounts payable (407,972) 887,560
Accrued liabilities 1,268,358 2,016,556
Current liabilities held for sale 0 (732,028)
Other current liabilities 0 58,246
Net cash provided by operating activities 4,497,315 3,055,920
Purchase of property and equipment (88,848) (176,928)
Capitalized software (2,352,959) (1,449,047)
Purchase of monitoring equipment and parts (880,851) (1,448,278)
Net cash used in investing activities (3,322,658) (2,325,538)
Proceeds from loan payable 21,000,000 0
Principal payments on long-term debt (23,520,000) (11,399)
Proceeds from Issuance or Sale of Equity 10,312,053 0
Payment of stock and warrant issuance costs (2,357,387) 0
Payment of deferred financing fees (2,303,803) (52,440)
Net cash used in financing activities 3,130,863 (63,839)
Effect of exchange rate changes on cash (15,045) (337,439)
Net decrease in cash 4,290,475 329,104
Cash, beginning of period 4,098,114 4,581,625
Cash, end of period 8,388,589 4,910,729
Cash paid for interest 221,211 48,936
Cash paid for taxes 92,846 92,107
Noncash Investing and Financing Items [Abstract]    
Issuance costs in accounts payable 2,262,500 0
Deferred financing fees in accounts payable 234,899 0
Deferred financing fees in exchange for a long term liability 750,000 0
Deferred financing fees in exchange for liability warrants 755,268 0
Monitoring Equipment [Member]    
Noncash Investing and Financing Items [Abstract]    
Purchase of monitoring equipment in accounts payable 64,423 0
Capitalized Software [Member]    
Noncash Investing and Financing Items [Abstract]    
Purchase of monitoring equipment in accounts payable 101,571 0
Property and Equipment [Member]    
Noncash Investing and Financing Items [Abstract]    
Purchase of monitoring equipment in accounts payable 5,571 0
Track Group Chile [Member]    
Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract]    
Loss on sale of subsidiary (630,472) 66,483
Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract]    
Proceeds from sale of subsidiary, net of cash included in sale $ 0 $ 748,715